Plain-English translation of NCT07290569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help people with moderate-to-severe plaque psoriasis (a skin condition causing thick, scaly patches). Researchers want to figure out which dose works best and is safest. You would receive one of several different dose levels of the medication or a placebo (inactive treatment) for about 28 weeks, then continue in a maintenance phase for about 72 more weeks.
Currently, many people with moderate-to-severe psoriasis still don't have good treatment options that work for them. This study is designed to find out if this new medication could be an effective and safe alternative, and to determine the best dose to use.
You likely qualify if…
You likely don't qualify if…
You would visit the study clinic regularly over about 2 years (roughly 100 weeks total). During the first 28 weeks (induction phase), you'd receive injections or doses of the medication or placebo according to your assigned group. Then you'd enter a maintenance phase for about 72 weeks where your dose may be adjusted based on how well the treatment is working. Throughout the study, doctors would monitor your skin, check for side effects, and run blood tests to make sure you're safe.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States